Embed Size (px)
Citation preview
Aleafia Health Inc Confidential & Proprietary
Corporate PresentationMay 2019
TSX: ALEF – OTC: ALEAF
Confidential & Proprietary 2
Certain Statements herein relating to the Company constitute “forward looking statements” within the meaning ofCertain statements herein relating to the Company constitute “forward looking statements”, within the meaning of applicable securities laws, including without limitation, statements regarding future estimates, business plans and/or
objectives, sales programs, forecasts and projections, assumptions, expectations, and/or beliefs of future performance, are “forward-looking statements”. Such “forward-looking statements involve unknown risks and
uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Forwardlooking statements include, but are not limited to, statements with respect to commercial operations,
including production and/or sales of marijuana, quantities of future marijuana production, anticipated revenues in connection with such sales, the overall projected size of the market, completion and/or expansion of production
facilities, and other Information that is based on forecasts of future results, estimates of production not yet determinable, and other key management assumptions. Actual results may differ materially from those expressed or
implied by such forwardlooking statements and involve risk and uncertainties relating to the Company’s historical experience with regulatory changes, timeliness of government approvals for the granting of permits and licenses, changes in marijuana prices, actual operating performance of facilities , and other uninsured risks. The Company
assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Contents are provided for general information purposes only and do not constitute an offer
to sell or solicitation of an offer to buy any security in any jurisdiction
2Confidential & Proprietary
Confidential & Proprietary
March 2019TSX Up-listing
TSX: ALEF
10 MillionPoint Medical
Cannabis Dataset
TSX VentureTop Performing Company of the Year
International Expansion
Germany | Australia
$476Million Market Capitalization
138,000 kgPlanned, Funded
CultivationCapacity
50,000 kgPlanned, Funded
Extraction Capacity
3Production & Cultivation Facilities
3
60,000Medical Patients
SCIENCEData analytics and science-based medicine inform every decision, from strains to treatment. If it matters, measure it.
SEEDINGWe seed change by disrupting established industries. Cross-platform integration and cannabis innovation is how we do it.
WELLNESSSpecialized treatment programs, tailored cannabis education courses, and product innovation. We deliver wellness through diversification.
Confidential & Proprietary 4
We GrowTogether
With continuous innovation, research & development;
we are creating the industry’s most reliable
cannabis health & wellness consumer experience
Confidential & Proprietary 5
4 divisions1 journey
Continuous innovation,
powered by technology
to scale globally.
Our Ecosystem
We GrowTogether
5
We drive continuous innovationin cannabis cultivation, processing,
extraction and brand-building to deliver science-based cannabis
health and wellness products for Aleafia Health consumers.
FoliEdge Academy Cannabis ConsumerExperience
We leverage our global leading medical patient experience to create and share innovative courseware for MDs, nurses,
patients, families and employers. Our responsibility is to lead and share our expertise in cannabis
health and wellness.
We educate, diagnose, treat and empower people to optimize
health and wellness with cannabinoid therapy. From pain
and anxiety, to paediatrics epilepsy and autism, we are there
for our patients - in hospitals, clinics and in their homes via
online telemedicine.
We are creating a unique, global, multi-jurisdictional
compliant, ecommerce consumer marketplace. It is a scalable,
cannabis sales platform that will complement our current national distribution network of provincial government and retail channels.
Health & Wellness Service Clinics
Cannabis Product Innovation
Confidential & Proprietary 6
We GrowTogether
Securing Repeatable High-Margin
Purchases
Seeding Customer Loyalty
Integrating the Consumer Journey
6
Cannabis Product &Consumer Journey
Cannabis Product Journey
Cannabis Consumer Journey
Extraction Processing
Grow &Quality Control
Cultivation
Distribution
Canada > Global
Learning & Sharing
Doctor / Patient
Engagement
Education
Cannabis Products & Brands
Marketplace Purchase
Product & Brands
Information & Awareness
Research
Our Ecosystem
Confidential & Proprietary 7
Port Perry, ON
7,000 sq. ft.Indoor hydroponic cultivation facility
Port Perry, ON
1.1M sq. ft. Prime agricultural farmland dedicated to outdoor cultivation
$0.25 cost per gram target
Facility Complete.
Niagara, ON | Greenhouse
160,000 sq. ft.Modern, automated moving container bench system to produce repeatable, standardized cannabis strains
Product Innovation Centre
25,000 sq. ft.Currently extracting oils, tinctures, sprays, gel caps
50,000 kg Extraction Phase II Expansion nearing completionFormulation and analytical laboratory built to GMP certifications
Low-Cost Supply
38,000 kg annual low-cost supplyIncluding largest ever LP-to-LP supply agreement
Paris, ON
83-AcresPrime agricultural land – zoned for industrial use. Internal best-use study currently underway.
Paris, ON
2,000kgMulti-format production capacity within Product Innovation Centre
Continuous innovation, powered by in-house medical and product expertise
Port Perry (Indoor): Cultivation& Wholesale Licenses
Niagara (Greenhouse): Cultivation Licence (expected Q2/19) Port Perry (Outdoor): Local Approval,Cultivation License (expected early Q2/19)
Paris (Product Innovation): Cultivation, Medical & Non-medical Sales, and Processing Licences
Confidential & Proprietary 8
160,000 sq. ft. Niagara
Greenhouse
Retrofitting & Construction Complete May 2019
Confidential & Proprietary 99
60,000 kg Outdoor Grow
Expansion
1.1 million sq. ft.Cultivation Area
Facility Build-out Complete
Confidential & Proprietary 1010
50,000 kg Extraction Expansion
Paris Phase II
Product Call Centre Build-out Complete
Construction Complete June 2019
Operational Ready in Mid-Q319Phase II
Expansion
Confidential & Proprietary 111111
Premium Non-MedicalPremium Medical
Wholesale
Value
Mid-Point
Cannabis Health & WellnessCapturing High Margins Within Industry Growth Segments
$14.52Aleafia Health average oil per gram selling price: “One of the highest amongst peers.”-Leading bank analyst
VS.
$8.02Average price per gram sold in Canada-Statistics Canada
Industry leadingprice per gram sold with premium products and strong health &wellness consumerbrand awareness.
Legal Cannabis Market Growth
Premium Pricing With Brand Awareness &Product Innovation
2025$146Billion Total
Today
Medical
$100Billion
Non-Medical
Confidential & Proprietary
Confidential & Proprietary 12
Continuous productInnovation. Powered byresearch, experience,consumer brand awareness and loyalty.
Established Cannabis Brands
Proven Cannabis Consumer Products
Quality Grown Cannabis Strains
THC – CBD – HybridsSativa – Indica - Hybrids
Market Leading Format BreadthFlower, Oil, Capsules, Sprays
High Quality Premium Medical Cannabis Products Focused on High Margins
Commercially Proven Non-Medical Cannabis Products (Adult-Use / Recreational)
Future CPG Brand Integrations Focused on Health & Wellness Lifestyle Products
Confidential & Proprietary
Retailers
Canada Medical
Canada Non-MedicalAdult-Use / Recreational
National, Global Distribution Platform
Global Export
• Canada’s largest clinic network • 900+ Canadian MDs and
Nurse Practitioners• 60,000+ Patients
Highly coveted supply agreement with Shoppers Drug Mart
International Export
Provincial Distribution
Health & Wellness Services
Listing with Canada’s largest pharmacy
Global Expansion
131. Pending regulatory approval.
Confidential & Proprietary
Built for Businesses,Corporations, Colleges /Universities, Governments,Associations, Regulatory Bodies,Unions, Insurance, Benefits
Joint medical cannabis study to improve the management and treatment of insomnia and
daytime sleepiness.
Cannabinoid pharmacogenetics in medical cannabis therapy study with
G420 and AKESOgen. Study in progress.
Of patients who stopped using benzodiazepines following medical cannabis treatment. Published in Journal of
Cannabis & Cannabinoid Research.
45%Epileptic patients improved employment status
in first of its kind, 4000 patient study To be published in Journal of Drug Issues. We Grow
Together
14
10 millionpoint
medical cannabis dataset
Continuous research
powered by technology to
seed wellness
...driving new cannabis products and services
Treatment Innovation
Confidential & Proprietary
Health & Wellness Services / Clinics
Patient on-boarding, diagnosing and treatments tuned
over 4+ years across hundreds of thousands of patient
encounters.
Global Medical Cannabinoid Therapy Expertise
Diagnosis, treatment and scripting by Physicians,
Nurse Practitioners in-clinic and by video
conference / Tele-Medicine at home.
All patient data monitored and collected,
from scripting, diagnosis, to purchasing.
Experienced Patient Journeys
60,000+Patients Seen to Date
Canada’s Largest Medical Cannabis Clinical Network
Dr. Michael VerboraChief Medical Officer
• Over 4000 cannabinoid therapy consultations
Focus Areas For Cannabinoid TherapyPain Cancer
Anxiety Palliative Care
Gastrointestinal Diseases Neurological DisordersPaediatrics Epilepsy Paediatrics Autism
15
10 MillionPoint Medical
Cannabis Dataset
We GrowTogether
Confidential & Proprietary
Courses• Cannabis 101, Cannabis in
the Workplace
• For Doctors, Nurses, Healthcare Professionals
• Patients & Family Members
+ Certifications & Licensing
Software-as-a-ServiceLearning ManagementSystem (LMS)
AnimationVideoNarrationInteractivityGamificationSocial SharingStudent Management
Built for Corporations, Colleges & Universities, Governments,Associations, Regulatory Bodies,Unions, Insurance Providers
Powered by ExperiencePatients, Engagements, Case Studies
Proprietary Research
Global Edgewith 4+ years,
60,000 patients
We GrowTogether
16
Continuous research and
patient engagement
powered by science
seeding learning
COMING SOON
In partnership with
Global Scale
Confidential & Proprietary
Continuous consumermarketplace innovation,powered by technologyto scale globally
Global data warehousesupporting all 4 divisionswith leading cannabisreporting, analytics,business insights, and AI
Gamification, reward &loyalty platform
Subscription and HomeDelivery Support
Consumer brandambassadors supportingphone, chat, emailand social consumerengagements
OnlineMarketplaceMedical and Non-Medical1
(Adult-Use / Recreational)
ProprietaryscalingeCommercePlatformConsumer Journey ofPurchasing MedicalCannabis Products Online
The Health & Wellness CannabisConsumer Experience & Lifestyle
We GrowTogether
17
Health & WellnessCannabis Lifestyle &Experience
We are where our consumers are
Continuous personalization,
powered by technology to
deliver exceptional consumer
experiences.
Our Marketplace
COMING SOON1. When and where permitted by federal and local law.
Multi-jurisdiction compliance,multi-language and multi-currency
18
William Stewart Lea Ray Daniel Milliard
Raf Souccar Loreto Grimaldi Mark Sandler
Board
Julian FantinoChairman
“Trust and accountability are paramount. To our team, to our shareholders, and to our patients.”
Confidential & Proprietary 19
Geoff Benic
Chief Executive Officer
Benjamin Ferdinand
Chief Financial Officer
Trevor Newell
Chief Marketing & Technology Officer
Dr. Michael Verbora
Chief Medical Officer
Keith White
President of Clinics
Lucas Escott
SVP Production
“By seeking a new form of care, our patients have the courage to do things
differently. They are our inspiration, and that differentiation our mantra.”
Management
Confidential & Proprietary 20
$476 Million Market Capitalization1
3 Cultivation / Extraction Facilities
138,000 kg Funded, Planned Cultivation Capacity
50,000 kg Funded, Planned Extraction Capacity
1,723% Year-over-Year Revenue Increase
78 Product SKUs
163 Acres of Land Owned
Confidential & Proprietary
Investment Highlights
1. At market close, 10/05/19
2. Aleafia Health Q1-19 v. Q1-1820
Confidential & Proprietary
60,000+Patients Seen to Date
Canada’s Largest Medical Cannabis Clinical Network
1.1 million sq. ft. Outdoor Grow
Nicholas BergaminiVP Investor Relations & Communications
[email protected] AleafiaHealth.com
21
10 MillionPoint
MedicalCannabis Dataset
Proprietary, globally scaling eCommerce Platform
160,000 sq. ft.Automated Niagara Greenhouse
